Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06567704
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-20
Brief Title:
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer NSCLC a Qualitative Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer NSCLC a Qualitative Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is to understand cancer related fatigue in patients with non-small cell lung cancer NSCLC who are being treated with an immune checkpoint inhibitor
Detailed Description:
This is an observational pilot study The target population includes non-dyad caregivers and adult patients diagnosed with inoperable NSCLC receiving an immune checkpoint inhibitor and report concerns of fatigue to their provider and caregivers This study will be conducted at Levine Cancer Institute LCI and Atrium Health Wake Forest Baptist Comprehensive Cancer Center AHWFBCCC This study consists of qualitative interviews at two-time points the primary and the follow-up During the primary interview patients with NSCLC will be asked to complete the PROMIS Fatigue-Short Form 7a consisting of seven items and caregivers will be asked to complete the Cancer Caregiving Tasks Consequences and Needs Questionnaire CaTCoN form consisting of 5-items in the caregiving workload subscale During the follow-up interviews participants will be asked about any change in their fatigue and views on physical activity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None